
6.86 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 2.57 Today|||52-Week Range 7.34 | +117.78% Year-to-Date |
What Makes Concert (CNCE) a Good Fit for "Trend Investing" Aug 05 / Zacks.com - Paid Partner Content | Concert Pharmaceuticals (CNCE) Reports Q2 Loss, Lags Revenue Estimates Aug 04 / Zacks.com - Paid Partner Content |
Does Concert (CNCE) Have the Potential to Rally 158% as Wall Street Analysts Expect? Aug 04 / Zacks.com - Paid Partner Content | Rigel Pharmaceuticals (RIGL) Reports Q2 Loss, Tops Revenue Estimates Aug 02 / Zacks.com - Paid Partner Content |
Previous close | 6.62 |
Today’s open | 6.62 |
Day’s range | 6.47 - 7.32 |
Volume | 71,405 |
Average volume (3 months) | 690,127 |
Market cap | $284.8M |
Earnings growth (last year) | +2.91% |
Earnings growth (this year) | -18.56% |
Earnings growth (next 5 years) | +10.90% |
Revenue growth (last year) | +312.28% |
P/E ratio | NM |
Price/Sales | 3.33 |
Price/Book | 1.90 |
Today’s change | Today’s % change | |
---|---|---|
--China Health Group I... | 0.00 | 0.00% |
FULCFulcrum Therapeutics... | -0.28 | -3.65% |
--Photocure ASA | 0.00 | 0.00% |
EVLOEvelo Biosciences In... | -0.31 | -10.30% |
Next reporting date | November 10, 2022 |
EPS forecast (this quarter) | -$0.59 |
Annual revenue (last year) | $32.6M |
Annual profit (last year) | -$80.1M |
Net profit margin | -245.72% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Lexington, Massachusetts |